Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 384

1.

Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome.

Abdel-Latif ME, Osborn DA.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD008310. doi: 10.1002/14651858.CD008310.pub2. Review.

PMID:
23076945
2.

Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.

Abdel-Latif ME, Osborn DA.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008309. doi: 10.1002/14651858.CD008309.pub2. Review.

PMID:
21735428
3.

Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome.

Abdel-Latif ME, Osborn DA.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD008311. doi: 10.1002/14651858.CD008311.pub2. Review.

PMID:
21412918
4.
5.

Intratracheal Clara cell secretory protein (CCSP) administration in preterm infants with or at risk of respiratory distress syndrome.

Abdel-Latif ME, Osborn DA.

Cochrane Database Syst Rev. 2011 May 11;(5):CD008308. doi: 10.1002/14651858.CD008308.pub2. Review.

PMID:
21563168
6.
8.

Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.

Bahadue FL, Soll R.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD001456. doi: 10.1002/14651858.CD001456.pub2. Review.

PMID:
23152207
9.

Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates.

De Paoli AG, Davis PG, Faber B, Morley CJ.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD002977. doi: 10.1002/14651858.CD002977.pub2. Review.

PMID:
18254011
10.
11.

Intra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns.

Abdel-Latif ME, Osborn DA, Challis D.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007916. doi: 10.1002/14651858.CD007916.pub2. Review.

PMID:
20091659
12.

Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants.

Subramaniam P, Ho JJ, Davis PG.

Cochrane Database Syst Rev. 2016 Jun 14;(6):CD001243. doi: 10.1002/14651858.CD001243.pub3. Review.

PMID:
27315509
13.

Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.

Pfister RH, Soll R, Wiswell TE.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006180. doi: 10.1002/14651858.CD006180.pub2. Review.

PMID:
19821357
14.

Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates.

De Paoli AG, Davis PG, Faber B, Morley CJ.

Cochrane Database Syst Rev. 2002;(4):CD002977. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD002977.

PMID:
12519580
15.

Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.

Soll R, Ozek E.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD000141. doi: 10.1002/14651858.CD000141.pub2. Review.

PMID:
19160177
16.

Continuous distending pressure for respiratory distress in preterm infants.

Ho JJ, Subramaniam P, Davis PG.

Cochrane Database Syst Rev. 2015 Jul 4;(7):CD002271. doi: 10.1002/14651858.CD002271.pub2. Review.

PMID:
26141572
17.
18.
19.

Antithrombin for respiratory distress syndrome in preterm infants.

Bassler D, Millar D, Schmidt B.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005383. Review.

PMID:
17054254
20.

Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.

Singh N, Halliday HL, Stevens TP, Suresh G, Soll R, Rojas-Reyes MX.

Cochrane Database Syst Rev. 2015 Dec 21;(12):CD010249. doi: 10.1002/14651858.CD010249.pub2. Review.

PMID:
26690260

Supplemental Content

Support Center